Key risks
- Consecutive losses across 8 quarters (₹20.77 Cr in Dec 2024, ₹4.53 Cr in Mar 2025) with negative ROE (-2.8%)—verify operational viability and path to profitability
- Revenue not disclosed for any recent quarter—verify sales trajectory, cost structure, and whether normal operations are occurring
- Public shareholders illiquid: 7.18% float with zero FII/DII participation
- Stock's 52-week range (₹7.87–₹101.99) indicates extreme volatility—verify sustainability of current valuation
Generated analysis · source review pending